Claim Missing Document
Check
Articles

Found 3 Documents
Search

Efficacy of Adjuvant Therapy Curcuma Longa Rhizome Extract and Moringa Oleifera Leaf Extract to Wound Healing in Leprosy Ulcer Patients Renni Yuniati; Farmaditya Eka Putra Mundhofir; Sylvia Christiana Sugianto
Journal of Social Research Vol. 4 No. 6 (2025): Journal of Social Research
Publisher : International Journal Labs

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55324/josr.v4i6.2565

Abstract

Leprosy (Morbus Hansen) is a chronic infectious disease caused by Mycobacterium leprae, primarily affecting the peripheral nerves and leading to sensory loss and the formation of chronic ulcers. This study investigates the efficacy of Curcuma longa rhizome and Moringa oleifera leaf extracts, known for their antibacterial and anti-inflammatory properties, in promoting wound healing in leprosy-related ulcers. Utilizing a pre-post, randomized, single-blinded controlled trial design, the study was conducted at Kelet Regional Hospital, Jepara, from January to April 2024. Participants included leprosy ulcer patients with a mean disease duration of 101.5 months, predominantly male (63.6%), and largely in the 51–60 age group (39.4%). Results indicated significant improvements in PUSH (Pressure Ulcer Scale for Healing) scores from pre-test to post-test within both the intervention and control groups (p<0.001). However, intergroup analysis showed no statistically significant difference in PUSH scores between groups (pre-test p=0.669; post-test p=0.198). These findings suggest that while C. longa and M. oleifera extracts have promising therapeutic potential in enhancing ulcer healing, their clinical efficacy may be limited by factors such as oral bioavailability. This research contributes to the limited literature on the use of plant-based adjunctive therapies in leprosy ulcer management and underscores the need for further studies with larger samples and improved delivery mechanisms to optimize clinical outcomes.
Efektivitas Ekstrak Kaempferia Galanga Terhadap Proses Penyembuhan Luka Renni Yuniati; Farah Chilwa Hidayati; Muhammad Auzinal Haq; Muhammad Ahda Sabila
Jurnal Impresi Indonesia Vol. 4 No. 6 (2025): Jurnal Impresi Indonesia
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Wound healing is a complex biological process that involves various stages of tissue regeneration. In the world of traditional medicine, Kaempferia galanga is widely known for its content of active compounds that have anti-inflammatory, antimicrobial, and antioxidant properties. This study aims to systematically review the adjuvant therapeutic efficacy of Kaempferia galanga rhizome extract in accelerating wound healing based on published experimental studies. This research method uses a systematic literature review approach by examining articles from national and international scientific databases over the past ten years. The results of the study show that the administration of Kaempferia galanga extract can increase re-epithelialization, reduce inflammatory response, and accelerate the formation of granulated tissue. Overall, rhizome-based adjuvant therapy Kaempferia galanga has the potential to be an alternative in the development of more natural and safe wound-healing agents. The conclusions of this study emphasize the importance of further exploration through clinical trials to ensure the effectiveness and safety of its long-term use in medical practice.
Leprosy in the Era of Zero-Leprosy Targets: Pathobiology, Clinical Care, Prevention, and Implementation Priorities Renni Yuniati; Farah Chilwa Hidayati; Muhammad Auzi’nal Haq
Al Makki Health Informatics Journal Vol. 4 No. 1 (2026): Al Makki Health Informatics Journal
Publisher : Al Makki Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.57185/a3dk2q86

Abstract

Leprosy (Hansen disease) is a chronic infectious disease caused predominantly by Mycobacterium leprae and, in a smaller number of cases, Mycobacterium lepromatosis. Although multidrug therapy (MDT) has made leprosy curable and has markedly reduced prevalence, approximately 200,000 new cases are reported annually, with Brazil, India, and Indonesia carrying the largest burdens. This narrative review synthesizes World Health Organization guidance and peer-reviewed literature published between 2018 and 2026, with seminal older sources retained, identified in PubMed, Scopus, WHO IRIS, Google Scholar, and the Indonesian databases Garuda and SINTA, to map the distance between biomedical cure and programme-level elimination. Clinical expression is heterogeneous because host immunity determines the balance between bacillary control, inflammation, and nerve injury. Diagnosis remains primarily clinical and is anchored by three cardinal signs. The main therapeutic regimen is rifampicin, dapsone, and clofazimine for 6 months in paucibacillary disease and 12 months in multibacillary disease. However, MDT alone is insufficient to interrupt transmission or prevent disability. Contact screening, single-dose rifampicin post-exposure prophylaxis, active case finding, early recognition of neuritis and leprosy reactions, rehabilitation, and stigma reduction are necessary components of a contemporary control programme. Its distinctive contribution is an explicit Indonesia-focused implementation perspective linking national epidemiological data, detection delay, and stigma to measurable programme indicators. Priority research areas include field-ready diagnostics, surveillance of antimicrobial resistance, predictive biomarkers for nerve injury, and delivery models that integrate affected persons and communities into prevention and care.